ABCG2 and neoplasm: By delivering specific gene editing tools (e.g., CRISPR-Cas9 system) or small interfering RNA (siRNA) to tumor cells, it is possible to down-regulate the expression or function of ABC transporter proteins, thus reversing the resistance mechanism of drug efflux [105].